192 related articles for article (PubMed ID: 31865744)
1. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
Vozoris NT
Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
[TBL] [Abstract][Full Text] [Related]
2. A critical review of the respiratory benefits and harms of orally administered opioids for dyspnea management in COPD.
Vozoris NT
Expert Rev Respir Med; 2021 Dec; 15(12):1579-1587. PubMed ID: 34761704
[TBL] [Abstract][Full Text] [Related]
3. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
4. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
[TBL] [Abstract][Full Text] [Related]
5. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
Varkey B
Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
[TBL] [Abstract][Full Text] [Related]
6. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
[TBL] [Abstract][Full Text] [Related]
7. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?
Horton R; Rocker G; Currow D
Curr Opin Support Palliat Care; 2010 Jun; 4(2):92-6. PubMed ID: 20443250
[TBL] [Abstract][Full Text] [Related]
8. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.
Ekström M; Nilsson F; Abernethy AA; Currow DC
Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110
[TBL] [Abstract][Full Text] [Related]
9. [Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids].
Ficker JH; Brückl WM
Pneumologie; 2019 Jul; 73(7):430-438. PubMed ID: 31291670
[TBL] [Abstract][Full Text] [Related]
10. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.
Marciniuk DD; Goodridge D; Hernandez P; Rocker G; Balter M; Bailey P; Ford G; Bourbeau J; O'Donnell DE; Maltais F; Mularski RA; Cave AJ; Mayers I; Kennedy V; Oliver TK; Brown C;
Can Respir J; 2011; 18(2):69-78. PubMed ID: 21499589
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Opioid-related Adverse Pulmonary Events among Older Adults with Chronic Obstructive Pulmonary Disease.
Vozoris NT; Pequeno P; Li P; Austin PC; O'Donnell DE; Gershon AS
Ann Am Thorac Soc; 2020 Aug; 17(8):965-973. PubMed ID: 32396385
[No Abstract] [Full Text] [Related]
12. Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.
O'Donnell DE; Webb KA; Harle I; Neder JA
Expert Rev Respir Med; 2016 Jul; 10(7):823-34. PubMed ID: 27115291
[TBL] [Abstract][Full Text] [Related]
13. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.
Rocker G; Young J; Donahue M; Farquhar M; Simpson C
CMAJ; 2012 Jun; 184(9):E497-504. PubMed ID: 22529167
[TBL] [Abstract][Full Text] [Related]
14. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids.
Rocker G; Horton R; Currow D; Goodridge D; Young J; Booth S
Thorax; 2009 Oct; 64(10):910-5. PubMed ID: 19786716
[TBL] [Abstract][Full Text] [Related]
15. Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists.
Young J; Donahue M; Farquhar M; Simpson C; Rocker G
Can Fam Physician; 2012 Jul; 58(7):e401-7. PubMed ID: 22798476
[TBL] [Abstract][Full Text] [Related]
16. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
17. [Opioids for refractory dyspnoea in palliation].
Aabom B; Bendstrup E; Sjøgren P; Løkke A; Shaker B; Wilcke T; Jespersen BA; Hilberg O; Marsaa K
Ugeskr Laeger; 2020 Sep; 182(40):. PubMed ID: 33000737
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
[TBL] [Abstract][Full Text] [Related]
19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
20. Barriers to Prescribing Opioids in the Management of Chronic Breathlessness in COPD: A Review.
Keogh E; Williams EM
COPD; 2021 Dec; 18(6):713-722. PubMed ID: 34761726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
